__NUXT_JSONP__("/drugs/VEGFR2PDGFRc-KitFlt-3_Inhibitor_SU014813", (function(a,b,c,d){return {data:[{drug:{slug:b,emaEpar:[],fdaDrugLabel:[],id:b,nciThesaurus:{casRegistry:a,chebiId:a,chemicalFormula:a,definition:"An orally-active, tyrosine kinase receptor inhibitor with potential antitumor activity. SU014813 binds to and inhibits the phosphorylation of vascular endothelial growth factor receptor 2 (VEGFR2), platelet-derived growth factor receptor (PDGFR) alpha and beta, c-Kit and Fms-related tyrosine kinase 3 (Flt-3). This leads to an inhibition of cellular proliferation and angiogenesis and an induction of apoptosis.",fdaUniiCode:"ZZ6VH5MZ17",identifier:"C61507",preferredName:c,semanticType:"Pharmacologic Substance",subclassOf:["C1967","C1971"],synonyms:["SU-14813",c]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FVEGFR2PDGFRc-KitFlt-3_Inhibitor_SU014813",extension:".json",createdAt:d,updatedAt:d}}],fetch:{},mutations:void 0}}("","VEGFR2PDGFRc-KitFlt-3_Inhibitor_SU014813","VEGFR2\u002FPDGFR\u002Fc-Kit\u002FFlt-3 Inhibitor SU014813","2021-10-30T13:41:34.443Z")));